ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 135 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $8,048,000 | +60.8% | 426,698 | +0.3% | 0.01% | +66.7% |
Q2 2019 | $5,005,000 | -3.9% | 425,222 | +11.5% | 0.00% | 0.0% |
Q1 2019 | $5,206,000 | +56.1% | 381,373 | +17.3% | 0.00% | 0.0% |
Q4 2018 | $3,334,000 | -38.9% | 325,190 | -0.8% | 0.00% | -25.0% |
Q3 2018 | $5,458,000 | +8.9% | 327,756 | +3.4% | 0.00% | 0.0% |
Q2 2018 | $5,010,000 | +32.1% | 317,082 | +6.2% | 0.00% | +33.3% |
Q1 2018 | $3,794,000 | +7.5% | 298,667 | -3.1% | 0.00% | 0.0% |
Q4 2017 | $3,530,000 | +10.6% | 308,250 | +18.4% | 0.00% | 0.0% |
Q3 2017 | $3,191,000 | +42.6% | 260,434 | +33.3% | 0.00% | +50.0% |
Q2 2017 | $2,238,000 | -48.6% | 195,446 | -6.6% | 0.00% | -50.0% |
Q1 2017 | $4,353,000 | +22.3% | 209,273 | +22.3% | 0.00% | 0.0% |
Q4 2016 | $3,560,000 | -34.6% | 171,150 | +3.1% | 0.00% | -33.3% |
Q3 2016 | $5,440,000 | +37.8% | 165,990 | +5.0% | 0.01% | +20.0% |
Q2 2016 | $3,947,000 | +80.1% | 158,058 | +76.7% | 0.01% | +66.7% |
Q1 2016 | $2,191,000 | -24.2% | 89,448 | +2.2% | 0.00% | -25.0% |
Q4 2015 | $2,892,000 | +22.7% | 87,548 | +21.7% | 0.00% | +33.3% |
Q3 2015 | $2,357,000 | +49.6% | 71,932 | +141.8% | 0.00% | +50.0% |
Q2 2015 | $1,576,000 | +227.0% | 29,746 | +78.1% | 0.00% | +100.0% |
Q1 2015 | $482,000 | +41.3% | 16,700 | +42.7% | 0.00% | 0.0% |
Q4 2014 | $341,000 | +128.9% | 11,700 | 0.0% | 0.00% | – |
Q3 2014 | $149,000 | -36.6% | 11,700 | 0.0% | 0.00% | – |
Q2 2014 | $235,000 | – | 11,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |